Clinical Trial Update: Comparative Antiresorptive Efficacy Discontinuation of Denosumab [Phase 4]

View source ↗

Summary

A Phase 4 trial update on discontinuation of denosumab evaluating antiresorptive efficacy in osteoporosis conditions may influence management after stopping tre…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Osteoporosis
• Postmenopausal Osteoporosis

Drugs mentioned

• Denosumab (denosumab)

Snippet

Sponsor: Massachusetts General Hospital | Conditions: Osteoporosis, Postmenopausal, Osteoporosis | Phase 4 | Status: ACTIVE_NOT_RECRUITING